Action Required: Password Reset on Next Login
As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.
To reset your password, please visit the Reset Password page.
We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Octapharma AG
Headquarters: Lachen, Switzerland
Website: http://www.octapharma.com
Year Founded: 1983
Status: Private
BioCentury | Jul 22, 2021
Deals
July 21 Quick Takes: Turnstone’s $80M round to advance oncolytic virus, TIL programs
Plus: Vedanta, bluebird, Cytokinetics and more
BioCentury | May 8, 2020
Product Development
Japanese approval for Gilead’s remdesivir
Plus Plasma Alliance partners with NIAID; and three Chinese biotechs join to make antibody therapy
BioCentury | Apr 30, 2020
Product Development
Alliance advancing unbranded hyperimmune globulin product for COVID-19
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Apr 7, 2020
Product Development
COVID-19 roundup: Inovio starts vaccine trial; plus updates from RedHill, Hope, CytoDyn, Gilead, Takeda, AACR and UNC-Emory
BioCentury is providing this story for free given the urgent need for information about the COVID-19 crisis. For more analysis, sign up for our daily email.
BioCentury | Feb 11, 2017
Strategy
Building Bioverativ
How Biogen spinout Bioverativ plans to survive as stand-alone company
Items per page:
1 - 10 of 58